Skip to main content
Screener/Healthcare/Biotechnology

CRSP — CRISPR Therapeutics AG

NASDAQ
$54.85+2.43 (+4.63%)
Mid CapHealthcareFastest GrowingHigh Beta
$34.12
$78.48
$52.55
$55.85
EPS (TTM)$-6.22
P/E Ratio-8.05
Dividend Yield—
Market Cap$4.98B
Volume1.37M
Prev Close$52.42
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$1.5M-$122.9M$-1.28-3346.4%-8431.5%
Q4 '25$864K-$130.6M$-1.37-6770.8%-15117.2%
Q3 '25$889K-$106.4M$-1.17-7177.1%-11973.1%
Q2 '25$892K-$208.5M$-2.40-5477.7%-23379.9%
Q1 '25$865K-$136.0M$-1.58-6548.4%-15722.1%
Q4 '24$35.0M-$37.3M$-0.44100.0%-106.6%
Q3 '24$602K-$85.9M$-1.01-2550.0%-14276.1%
Q2 '24$517K-$126.4M$-1.49-10920.5%-24450.3%
Get Your Daily Market Recap
CRSP Stock Price, Chart & Analysis